Calyxo, a Pleasanton, CA-based medical device company developing next-generation treatment solutions for patients with kidney stones, raised $50M in Series D funding.
The round was led by Avidity Partners with participation from existing investors Questa Capital and CRG.
The company intends to use the funds to build commercial traction while maintaining investment in product development and clinical studies.
Led by President and CEO Joe Catanese, Calyxo is an innovation-driven medical device company focused on improving care for patients with kidney stones by delivering paradigm-shifting solutions that enable urologists to safely, effectively and efficiently achieve unrivaled clinical outcomes. The company is commercializing the CVAC Aspiration System which uses irrigation and aspiration to remove kidney stones with the goal of minimizing residual stone burden.
The technology has already been used to treat more than 1,300 patients in the U.S.
